Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(3)
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
10-year high
|
Strong Performer, Getting Expensive
794.4000
16.10
(
2.07
%)
NSE
Jul 09, 2025
15:31 PM
New 52W High today
Volume:
3.7M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
05 Aug 2019
10-year high
794.40
2.07%
Laurus Labs (BUY): High opex offsets formulation positives; expect recovery in Q2
Buy:
Laurus Labs Ltd.
by
BOB Capital Markets Ltd.
Target: 480
BOB Capital Markets Ltd.
Q1FY20 operational results were in line despite strong gross margin expansion.
Laurus Labs Ltd. has an
average target
of 649.60 from 5 brokers.
More from Laurus Labs Ltd.
Recommended
Market closes lower, Sarda Energy gets CSPDCL nod to source power from Rehar-1 hydro project
Trendlyne Marketwatch |
09 Jul 2025, 05:47PM
All in the family: Bajaj, Murugappa, Mahindra & Tata Group stocks outpace the benchmark
The Baseline |
09 Jul 2025, 04:24PM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020